Anti-cyclic citrullinated peptide antibody (anti-CCP antibody) is present in the sera of patients with dementia of Alzheimer's type in Asian

Acta Neurologica Scandinavica

Volumn 121, Issue 5, 2010, Pages 338-341

  Satoh, K ^a   Kawakami, A ^a   Shirabe, S ^a   Tamai, M ^a   Sato, A ^b   Tsujihata, M ^b   Nagasato, K ^c   Eguchi, K ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Nagasaki Kita Hospital   (Japan)

^c Isahaya General Hospital   (Japan)

Author keywords

Anti cyclic citrullinated peptide antibody; Dementia of Alzheimer's type

Indexed keywords

ARGINASE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; PEPTIDYLARGINASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; ASIAN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASIA; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PEPTIDES, CYCLIC;

EID: 77951118742     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2009.01217.x     Document Type: Article

References (14)

1. Ishigami A, Ohsawa T, Hiratsuka M et al. Abnormal accumulation of citrullinated proteins catalysed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res 2005 80 : 120 128.
2. Vossenaar ER, Radstake TR, van der Heijden A et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004 63 : 373 381.
3. Chang X, Yamada R, Suzuki A et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis. Rheumatology (Oxford, England) 2005 44 : 40 50.
4. Suzuki K, Sawada T, Murakami A et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 2003 32 : 197 204.
5. Yamada R, Suzuki A, Chang X, Yamamoto K. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene. Trends Mol Med 2003 9 : 503 508.
6. Suzuki A, Yamada R, Chang X et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003 34 : 395 402.
7. Iwamoto T, Ikari K, Nakamura T et al. Association between PADI4 and rheumatoid arthritis: A meta-analysis. Rheumatology (Oxford, England) 2006 45 : 804 807.
8. Nakayama-Hamada M, Suzuki A, Kubota K et al. Comparison of enzymatic properties between hPADI2 and hPADI4. Biochem Biophys Res Commun 2005 327 : 192 200.
9. van Gaalen FA, van Aken J, Huizinga TW et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004 50 : 2113 2121.
10. Mastronardi FG, Wood DD, Mei J et al. Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation. J Neurosci 2006 26 : 11387 11396.
11. Vossenaar ER, Despres N, Lapointe E et al. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004 6 : R142 50.
12. Chang X, Yamada R, Suzuki A, Kochi Y, Sawada T, Yamamoto K. Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology (Oxford, England) 2005 44 : 1374 1382.
13. Suzuki A, Yamada R, Ohtake-Yamanaka M, Okazaki Y, Sawada T, Yamamoto K. Anti-citrullinated collagen type I antibody is a target of autoimmunity in rheumatoid arthritis. Biochem Biophys Res Commun 2005 333 : 418 426.
14. Bodil Roth E, Theander E, Londos E et al. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary sjögren's syndrome, multiple sclerosis and alzheimer's disease. Scand J Immunol 2008 67 : 626 631.